Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $21.71 Average Price Target from Brokerages
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 […]
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 […]
